Anaplastic pilocytic astrocytoma

From Libre Pathology
Jump to navigation Jump to search

Anaplastic pilocytic astrocytoma, abbreviated APA, is an outdated tumor terminology. Most of these tumors are now classified either as High-grade astrocytoma with piloid features, Pleomorphic xanthoastrocytoma or as Glioblastoma, IDH-wildtype.

General

  • High-grade astrocytoma - behaviour corresponded in older classifications to WHO Grade III.
  • Some authors prefered the designation pilocytic astrocytoma with anaplastic features.
  • Less than 2% of all pilocytic astrocytomas.[1]
  • De novo cases in the setting of neurofibromatosis 1 reported.
  • Many tumors have history of previous radiation.

Old microscopic criteria

Features:[2]

  • At least 4 mitoses/10 high power fields - see HPFitis.
  • Hypercellularity.
  • Necrosis +/-.
  • Pilocytic like (biphasic) - most common.
    1. Eosinophilic granular bodies +/-.
  • Small cell (32%)
  • Epithelioid cells (15%)
  • Fibrillary areas resembling diffuse astrocytoma.

IHC

Features:[3]

  • GFAP +ve (fibres).
  • p53: +ve.
  • KI-67: high 25%.
  • ATRX loss may be present.[4]
  • IDH1 (R132H) -ve.
  • H3F3A (K27M) -ve.

See also

References

  1. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  2. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  3. Rodriguez, FJ.; Scheithauer, BW.; Burger, PC.; Jenkins, S.; Giannini, C. (Feb 2010). "Anaplasia in pilocytic astrocytoma predicts aggressive behavior.". Am J Surg Pathol 34 (2): 147-60. doi:10.1097/PAS.0b013e3181c75238. PMID 20061938.
  4. Ebrahimi, A.; Skardelly, M.; Bonzheim, I.; Ott, I.; Mühleisen, H.; Eckert, F.; Tabatabai, G.; Schittenhelm, J. (Jun 2016). "ATRX immunostaining predicts IDH and H3F3A status in gliomas.". Acta Neuropathol Commun 4 (1): 60. doi:10.1186/s40478-016-0331-6. PMID 27311324.